42nd Annual Advances in Heart Disease

Need Help?

Overview

Our 42nd annual course will again strive to present topics that highlight new evidence-based medicine findings reported within the last one to two years that impact clinical practice. These will range across a variety of cardiologic subspecialty interests including heart failure, arrhythmias, cardiac surgery, gene therapy, aortic diseases, prevention and artificial intelligence.

Our faculty will include a distinguished group of visiting academicians from North America together with outstanding teachers and clinicians from the University of California, San Francisco.

All sessions will be recorded and made available to participants for online viewing 30 days post course.

TARGET AUDIENCE 
This course is intended for cardiovascular specialists, practicing cardiologists, internists, family physicians, cardiovascular and critical care nurses, and physician assistants.

 

Onsite and Remote Learning Options:
The course will be offered as a live conference. Registrants have the option to attend in person or to tune in remotely via zoom live stream during programming hours (Pacific Time). Login instructions along with the digital syllabus will be shared with attendees before the meeting. Included in your registration fee is access to the course recordings on demand after the conference and for 30 days after the course. You must tune in to the live conference (in person or remotely) to claim CME.

Objectives

An attendee completing this course will be able to improve skills and strategies to:

• Provide the best management of coronary heart disease, hypertension, lipid disorders, diabetes, systolic and diastolic heart failure, atrial fibrillation, STEMI and non-STEMI, thromboembolic disease;
• Refine considerations for atrial fibrillation, atrial flutter, and ventricular tachycardia ablation;
• Apply the best considerations of percutaneous interventions for coronary heart disease;
• Improve the use of anti-platelet and anti-coagulation therapy for cardiovascular diseases;
• Recognize risk stratification of cardiovascular disease;
• Apply the best consideration of percutaneous treatment of valvular heart disease;
• Recognize that pathophysiology of diseases and treatment options are impacted by social determinants of health and implement strategies to improve health outcomes among all patients.

Accreditation

In support of improving patient care, the University of California, San Francisco is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

UCSF designates this live activity for a maximum of 18.75 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This CME activity meets the requirements under California Assembly Bill 1195, continuing education and cultural and linguistic competency.

Internal Medicine Physicians
Successful completion of this CME activity enables the participant to earn up to 18.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.  Attendees must complete the course evaluation within 30 days of the activity completion in order to receive MOC credit.

Nurses 
For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credits^TM issued by organizations accredited by the ACCME.

Physician Assistants 
AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA PRA Category 1 Credits^TM from organizations accredited by the ACCME.

Pharmacists 
The California Board of Pharmacy accepts as continuing professional education those courses that meet the standard of relevance to pharmacy practice and have been approved for AMA PRA Category 1 Credits^TM.

 

Course Outline

Course Director

Peter Ganz, MD, FACC
Professor, Division of Cardiology;
Director, Center of Excellence in Vascular Research,
UCSF at Zuckerberg San Francisco General Hospital

Co-Directors

Jonathan Davis, MD, MPHS
Cardiologist, Mercy Hospital, St. Louis MO
Formerly, Director of the Heart Failure Services, San Francisco Health Network

Nora F. Goldschlager, MD
Professor Emeritus of Medicine, Division of Cardiology
UCSF at Zuckerberg San Francisco General Hospital

Mary Gray, MD
Professor of Medicine, Division of Cardiology
Chief of Cardiology
UCSF at Zuckerberg San Francisco General Hospital

Lucas Zier, MD, MS
Associate Professor of Medicine, Division of Cardiology
UCSF at Zuckerberg San Francisco General Hospital

Faculty

(University of California, San Francisco unless indicated)

Yousif Ahmad, MBBS, PhD
Assistant Professor of Medicine, Division of Cardiology
Interventional Cardiology Program at UCSF Health

Alan Baik, MD, PhD
Assistant Professor of Medicine, Division of Cardiology
Director, Pericardial Disease Center at UCSF Health

Christopher Barnett, MD, MHP
Professor of Medicine, Division of Cardiology
Director, Cardiac Intensive Care Unit at UCSF Health
Chief of Critical Care Cardiology at UCSF Health

Ruth Dubin, MD
Associate Professor, Department of Internal Medicine, Division of Nephrology
Center for Mineral Metabolism and Clinical Research
University of Texas Southwestern
 
Sammy Elmariah, MD, MPH 
Leone-Perkins Family Endowed Professor of Medicine
Chief of Interventional Cardiology at UCSF Health

Michela Faggioni, MD
Assistant Professor of Medicine, Division of Cardiology
Interventional Cardiology Program at UCSF Health

Edward Gerstenfeld, MD, MS
Melvin Scheinman Endowed Professor of Medicine
Chief of Cardiac Electrophysiology and Arrhythmias at UCSF Health

Samuel Z. Goldhaber, MD
Professor of Medicine,
Harvard Medical School
Associate Chief and Clinical Director, Division of Cardiovascular Medicine
Director of the Thrombosis Research Group 
Brigham and Women’s Hospital

Liviu Klein, MD, MS
Professor of Medicine,
Director of Advanced Heart Failure Comprehensive Care Center at UCSF Health
Section Chief of Advanced Heart Failure, Mechanical Circulatory Support, 
Pulmonary Hypertension and Heart Transplant at UCSF Health

Albert Liu, MD
Assistant Professor of Medicine, Division of Cardiology
Electrophysiology and Arrhythmias Section at UCSF Health

John MacGregor, MD, PhD
Professor of Medicine, Division of Cardiology
Director of Cardiac Catheterization Laboratories, 
UCSF at Zuckerberg San Francisco General Hospital

Gregory Marcus, MD, MAS
Professor of Medicine, Division of Cardiology
Associate Chief of Cardiology for Research at UCSF Health

Daniel Morin, MD, MPH
Professor of Medicine, Division of Cardiology
Director, Cardiac Electrophysiology Laboratory at UCSF Health

Javid Moslehi, MD
Professor of Medicine, Division of Cardiology
Chief, Cardio-Oncology and Immunology at UCSF Health

Joshua Moss, MD, MS
Professor of Medicine, Division of Cardiology
Electrophysiology Fellowship Director at UCSF Health

Shweta Motiwala, MD, MPH
Associate Professor of Medicine, Division of Cardiology
Director of Heart Failure Disease Management at UCSF Health

Chiadi E. Ndumele, MD, PhD
Associate Professor of Medicine and Epidemiology, Division of Cardiology
Director of Obesity and Cardiometabolic Research
Director of the Heart Failure Prevention Program 
Johns Hopkins School of Medicine

Adam Oesterle, MD
Assistant Professor of Medicine, Division of Cardiology
Electrophysiology Section, UCSF at San Francisco VA Medical Center

Cara Pellegrini, MD
Professor of Medicine, Division of Cardiology
Director of Cardiac Electrophysiology, UCSF at San Francisco VA Medical Center

Pooja Prasad, MD
Assistant Professor of Medicine, Division of Cardiology
Advanced Heart Failure Comprehensive Care Center, UCSF Health

Paul M. Ridker, MD, MPH
Eugene Braunwald Professor of Medicine, Harvard Medical School
Director, Center for Cardiovascular Disease Prevention
Physician, Brigham and Women’s Hospital

Aarthi Sabanayagam, MD, MBBS
Associate Professor, Division of Cardiology
Co-Director, UCSF Pregnancy and Cardiac Treatment Program at UCSF Health

Carlos Santos-Gallego, MD
Instructor of Cardiology
Cardiovascular Institute, Icahn School of Medicine at Mount Sinai

Marc Simon, MD, MS
Edward Fein and Pearl Landrith Endowed Professor in Cardiology
Director of Pulmonary Vascular Disease and the Pulmonary Hypertension Comprehensive Care Center at UCSF Health

Krishan Soni, MD, MBA
Associate Professor of Medicine, Division of Cardiology
Director of Value Improvement for the Department of Medicine-UCSF Health Subspecialty Services

Joseph Yang, MD
Associate Professor of Medicine, Division of Cardiology
Interventional Cardiology Section, UCSF at San Francisco VA Medical Center

Travel & Lodging

Exhibitors

Exhibit Fee: $3,000
Email Contact for Exhibits [email protected]

Pay $3,000 Fee Via Credit Card

Exhibit Description

Exhibitors receive the following benefits:

•  (1) 6’ x 30” tabletop exhibit space at UCSF assigned location in exhibit hall
• Standard acknowledgement from the podium
• Acknowledgement in the course syllabus distributed to each registrant
• (2) complimentary exhibitor attendees

Exhibit Hours

(subject to updating)